MIRA Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Operating Revenue	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$8.53 M	$0.00	$0.00	$0.00
Gross Profit	-$8.53 M	$0.00	$0.00	$0.00
Gross Profit Ratio	0	0	0	0
Research and Development Expenses	$1.57 M	$2.35 M	$684,447.00	$14,647.00
General & Administrative Expenses	$6.50 M	$2.99 M	$770,115.00	$158,946.00
Selling & Marketing Expenses	$453,550.00	$0.00	$0.00	$52,823.00
Selling, General & Administrative Expenses	$6.95 M	$2.99 M	$770,115.00	$52,982.00
Other Expenses	$0.00	-$1.70 M	-$697,600.00	$0.00
Operating Expenses	$8.53 M	$7.05 M	$2.15 M	$67,629.00
Cost And Expenses	$8.53 M	$7.05 M	$2.15 M	$67,629.00
Interest Income	$0.00	$0.00	$0.00	$0.00
Interest Expense	-$3.46 M	$10,250.00	$24,374.00	$364.00
Depreciation & Amortization	$8.53 M	$7,047.94	$2,152.16	$202,887.00
EBITDA	-$8.53 M	-$7.05 M	-$2.15 M	-$67,630.00
EBITDA Ratio	0	0	0	0
Operating Income	-$8.53 M	-$7.05 M	-$2.15 M	-$67,630.00
Operating Income Ratio	0	0	0	0
Total Other Income/Expenses Net	-$3.46 M	-$10,250.00	-$24,374.00	-$363.00
Income Before Tax	-$11.98 M	-$7.06 M	-$2.18 M	-$67,993.00
Income Before Tax Ratio	0	0	0	0
Income Tax Expense	-$8,526.05	-$7,047.94	-$2,152.16	-$202.89
Net Income	-$11.98 M	-$7.06 M	-$2.18 M	-$67,993.00
Net Income Ratio	0	0	0	0
EPS	-0.65	-0.48	-0.15	-0.0046
EPS Diluted	-0.65	-0.48	-0.15	-0.0046
Weighted Average Shares Out	$18.57 M	$14.75 M	$14.75 M	$14.75 M
Weighted Average Shares Out Diluted	$18.57 M	$14.75 M	$14.75 M	$14.75 M
Link

MIRA Pharmaceuticals, Inc. (MIRA) Financials